EINDHOVEN, the Netherlands & LAUSANNE, Switzerland & BOSTON–(BUSINESS WIRE)–ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced that management will participate in the following upcoming events in October: Investors’ Day Geneva October 5, 2022 Geneva, Switzerland Dave Marver, … [Read more…]
LEO Pharma and DKSH have entered into an agreement to bring high-quality therapeutic products for dermatology and thrombosis to patients across Asia. This agreement both supports LEO Pharma’s strategy of building a simpler and more competitive organization and DKSH Business Unit Healthcare’s strategic focus of strengthening its regional footprint. BALLERUP, Denmark & BANGKOK, Thailand–(BUSINESS WIRE)–DKSH … [Read more…]
Appointment Strengthens Sales Operating Model To Accelerate Growth, Increase Productivity, and Intensify Focus on Key Markets SAN FRANCISCO–(BUSINESS WIRE)–Healthcare technology company Komodo Health today announced that Lauren Stahl has been appointed as the company’s Vice President and Head of Sales, effective immediately. In this capacity, Stahl’s responsibilities include sales team leadership across Komodo’s entire portfolio … [Read more…]
EMERYVILLE, Calif.–(BUSINESS WIRE)–Eureka Therapeutics, Inc., a clinical-stage biotechnology company developing novel T cell therapies to treat cancer, today announced the publication of a study in the New England Journal of Medicine entitled “GPRC5D-Targeted CAR T Cells for Myeloma.” The study was led by Dr. Eric Smith of the Dana-Farber Cancer Institute, Dr. Renier Brentjens of … [Read more…]
Expects to Emerge from Recapitalization Process in Coming Days with Strengthened Balance Sheet and Enhanced Financial Flexibility ROCHESTER, N.Y.–(BUSINESS WIRE)–Carestream Health (“Carestream” or the “Company”) today announced that the United States Bankruptcy Court for the District of Delaware (the “Court”) has confirmed the Company’s “prepackaged” restructuring plan. The Company expects to successfully complete its recapitalization … [Read more…]
WASHINGTON–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) welcomes the release of reports exposing the drug industry’s disinformation campaign attacking the 340B Drug Pricing Program. Ryan White Clinics for 340B Access last week published a rebuttal against the plethora of so-called ‘studies’ whose authors have financial ties to the drug industry. Ryan White Clinics for 340B Access (https://rwc340b.org/), … [Read more…]
Data continue to show compelling efficacy and safety, including improvement on all key measures of pain and disability, as compared to the one-year and two-year study results DUBLIN–(BUSINESS WIRE)–Mainstay Medical Holdings plc today announced the publication of the three-year patient outcomes data from its pivotal ReActiv8-B clinical trial. The data, published in the journal of … [Read more…]
Automation – AI-assisted Automatic Assessment and Automated Notifications enable doctors to prioritize treatment tracking exceptions to address treatment progress including patient compliance, key for teens and their parents Integration – Creates a seamless and intelligent, single-platform experience for doctors and their staff through integration with the Invisalign Doctor Site TEMPE, Ariz.–(BUSINESS WIRE)–Align Technology, Inc. (“Align”) … [Read more…]
IRVINE, Calif.–(BUSINESS WIRE)–#ESG–Sabra Health Care REIT, Inc. (“Sabra,” or “we”) (Nasdaq: SBRA) today released its second annual Sustainability Report. The report highlights Sabra’s priorities and initiatives on environmental stewardship, social commitment, corporate governance and community service. “We endeavor to operate efficiently, sustainably and in the best interest of our stakeholders,” said Rick Matros, Sabra’s Chair, … [Read more…]
Dr. Sans brings over two decades of life sciences experience spanning investment banking, corporate development, and clinical research LA JOLLA, Calif.–(BUSINESS WIRE)–Calidi Biotherapeutics, Inc. (Calidi), a clinical-stage biotechnology company that is pioneering allogeneic cell-based platforms to revolutionize oncolytic virus therapies, today announced the appointment of David Sans, FAARM, Ph.D, MBA, in New York as Head … [Read more…]
